Trending

#pulm

Latest posts tagged with #pulm on Bluesky

Latest Top
Trending

Posts tagged #pulm

Preview
Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities Pulmatrix (Nasdaq: PULM) announced that on February 28, 2026 Cullgen notified Pulmatrix it was terminating the previously agreed Merger Agreement, which remained subject to China Securities Regulatory Commission approval. Pulmatrix said it is pursuing alternative merger opportunities while continuing development of its inhaled clinical assets and iSPERSE™ technology.The company highlighted IND acceptance for PUR3100, Phase 1 data, ongoing PUR1800 development, and a Phase 3 pathway for PUR1900 with partner Cipla.

#PULM Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities

www.stocktitan.net/news/PULM/pulmatrix-anno...

0 0 0 0
Preview
Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results Pulmatrix (Nasdaq: PULM) reported year-end and Q4 2025 results and provided a corporate update on a proposed merger and asset monetization. Revenues fell to $0 in 2025 from $7.8M in 2024; net loss was $5.16M. Cash and equivalents were $4.1M at year-end, and management says funds are sufficient into Q1 2027. The company is pursuing licensing/monetization of its iSPERSE technology and three clinical programs including Phase 2-ready PUR3100; Cipla continues international development of PUR1900.

#PULM Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results

www.stocktitan.net/news/PULM/pulmatrix-anno...

0 0 0 0
Post image

I'm wishing you and your loved ones the best for 2026! 🎉

We all can use a fresh start. What are some of your goals for the new year?

#lunghealth #pulmonology #pulm

0 0 0 0
Preview
Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives Pulmatrix continues to support Cullgen in seeking approval for their merger from the China Securities Regulatory Commission. FRAMINGHAM, Mass., Dec. 18, 2025/ PRNewswire/-- Pulmatrix, Inc., a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases...

#PULM Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives

www.stocktitan.net/news/PULM/pulmatrix-and-...

0 0 0 0
Post image Post image Post image

🗣️ new episode out today!

A patient is following with you for progressive dyspnea and cough and recurrent pneumonias. Here is there CT progression 👇

Listen to our episode today that was a live presentation at CHEST 2025 to work through the case!

#pulm
#pccm

www.pulmpeeps.com/2025/11/11/1...

1 0 0 0
Post image Post image Post image

New episode out today wrapping up our asthma guidelines series!

www.pulmpeeps.com/2025/10/28/1...

Infographics below 👇

Stay tuned for our next guidelines series about Pulmonary Hypertension!

#pulm
#pulmcrit
#meded

2 0 0 0
Post image

🫁ARDS Mx (ATS 2024):

✅Lung-protective vent(Vt 4–8 mL/kg PBW, Pplat <30)
✅Prone >12 h/day for severe ARDS
🟡Consider: Steroids, VV-ECMO, NMB, higher PEEP (no LRMs)
🚫No HFOV & prolonged LRMs

@atscommunity.bsky.social
#ARDS #CriticalCare #Pulm #ICU

tinyurl.com/sxuwd3f5

1 0 0 0
Preview
Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets As part of the proposed merger, Pulmatrix currently intends to divest its assets including its proprietary dry powder delivery technology, iSPERSE™, which enables delivery of small- or large-molecule drugs to the lungs by inhalation to treat migraine and respiratory diseases. FRAMINGHAM, Mass., Oct. 16, 2025/ PRNewswire/-- Pulmatrix, Inc., a biopharmaceutical...

#PULM Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets

www.stocktitan.net/news/PULM/pulmatrix-anno...

0 0 0 0
Preview
Romantiline siidist pruudikimp Romantiline siidist pruudikimp igaks pulmaks. Avasta siidist pruudikimp, mis lisab su pulmapäevale ainulaadset romantilisust ja elegantsi. Telli täna!

Romantiline siidist pruudikimp: Romantiline siidist pruudikimp igaks pulmaks.

Avasta siidist pruudikimp, mis lisab su pulmapäevale ainulaadset romantilisust ja elegantsi. Telli täna! #romantiline #pulm #pruudikimp #siid #pulmaaksessuaarid

0 0 0 0
Preview
Pulma- ja peoaksessuaarid  Pulma- ja peoaksessuaaride valik iga sündmuse jaoks Otsid täiuslikke pulma- ja peoaksessuaare, mis muudaksid su erilise päeva veelgi meeldejäävamaks? Meie rikkalik aksessuaaride kollektsioon pakub kõike alates kaunistest pruudikimpudest ja kroonidest kuni elegantsete juuste pärgadeni. Iga toode on hoolikalt valitud, et tagada kvaliteet ja stiil, mis vastaks iga sündmuse vajadustele. Olgu see siis pulm, sünnipäev või muu pidulik sündmus, meie valik pakub sulle sobivaid lahendusi, mis on ühtaegu stiilsed ja taskukohased. Lisaks on meie e-poest tellimine lihtne ja mugav, olenemata sellest, kas elad Tallinnas, Tartus, Pärnus või mujal maailmas. Kõik tellimused saadetakse sulle tasuta kohaletoimetamisega. Avasta meie soodne valik ja vali oma sündmuse jaoks täiuslik aksessuaar juba täna!

Avasta uued soodsad pakkumised👉 Pulma- ja peoaksessuaarid:  Pulma- ja peoaksessuaaride valik iga sündmuse jaoks

Otsid täiuslikke pulma- ja peoaksessuaare, mis muudaksid su erilise päeva veelgi meeldejäävamaks? Meie rikkalik aksessuaaride… #pulmad #peoaksessuaarid #pulmaaksessuaarid #pulm #sünnipäev

0 0 0 0
Preview
Pulmatrix to Divest 146-Patent Inhalation Technology Portfolio as Cullgen Merger Advances Pulmatrix seeks buyers for iSPERSE™ inhalation technology with 146 patents amid strategic merger with Cullgen. Q2 results and merger timeline revealed. Learn more.

#PULM Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets

www.stocktitan.net/news/PULM/pulmatrix-anno...

0 0 0 0
Preview
Pulma- ja peoaksessuaarid Elegantne ja Soodne Pulma- ja Peoaksessuaaride Valik Iga Sündmuse Jaoks Otsid täiuslikke pulma- ja peoaksessuaare, mis muudaksid su erilise päeva veelgi meeldejäävamaks? Meie rikkalik aksessuaaride kollektsioon pakub kõike alates kaunistest pruudikimpudest ja kroonidest kuni elegantsete juuste pärjadeni. Iga toode on hoolikalt valitud, et tagada kvaliteet ja stiil, mis vastaks iga sündmuse vajadustele. Olgu see siis pulm, sünnipäev või muu pidulik sündmus, meie valik pakub sulle sobivaid lahendusi, mis on ühtaegu stiilsed ja taskukohased. Lisaks on meie e-poest tellimine lihtne ja mugav, olenemata sellest, kas elad Tallinnas, Tartus, Pärnus või mujal maailmas. Kõik tellimused saadetakse sulle tasuta kohaletoimetamisega. Avasta meie soodne valik ja vali oma sündmuse jaoks täiuslik aksessuaar juba täna!

Pulma- ja peoaksessuaarid: Elegantne ja Soodne Pulma- ja Peoaksessuaaride Valik Iga Sündmuse Jaoks

Otsid täiuslikke pulma- ja peoaksessuaare, mis muudaksid su erilise päeva veelgi meeldejäävamaks? Meie rikkalik aksessuaaride kollektsioon pakub kõike… #pulmad #peoaksessuaarid #pulm #sündmus #eelarve

0 0 0 0
Preview
Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets Pulmatrix (NASDAQ: PULM) reported Q1 2025 financial results and announced plans to divest its assets ahead of its proposed merger with Cullgen. The company reported zero revenue in Q1 2025, down from $5.9M in Q1 2024, and a net loss of $1.8M compared to a net income of $825K in Q1 2024. Cash position stands at $7.7M as of March 31, 2025. The company plans to divest key assets including its Phase 2-ready acute migraine candidate PUR3100, PUR1800 for AECOPD treatment, PUR1900 antifungal drug, and its proprietary iSPERSE™ technology platform. The merger with Cullgen, expected to close in June 2025, will create a Nasdaq-listed company focused on targeted protein degradation with three Phase 1 degrader programs for cancer and pain treatment.

#PULM Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets

www.stocktitan.net/news/PULM/pulmatrix-anno...

0 0 0 0
Preview
Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets Pulmatrix (PULM) announced its Q4 and full-year 2024 financial results, highlighting its planned merger with Cullgen expected to close in H1 2025. The company reported revenues of $7.8 million for 2024, up from $7.3 million in 2023. Research and development expenses decreased to $7.2 million from $15.5 million, while general and administrative expenses increased to $7.8 million from $6.5 million.As part of the merger strategy, Pulmatrix plans to divest its clinical assets, including the Phase 2-ready PUR3100 for acute migraine, PUR1800 for AECOPD, and PUR1900 antifungal treatment. The company's cash position stands at $9.5 million as of December 31, 2024, deemed sufficient until the merger completion.The company's iSPERSE™ technology portfolio includes 149 granted patents, with 19 U.S. patents expiring between 2024 and 2037, plus approximately 50 pending applications.

#PULM Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets

www.stocktitan.net/news/PULM/pulmatrix-anno...

0 0 0 0
Preview
Healthcare Workers vs Hunger Healthcare workers vs Hunger is an annual friendly competition between teams of healthcare workers to help relieve food insecurity.

Just donated to local food bank but waiting to log until there is a #pulm
#criticalcare team or something that speaks to me. Someone help me out #hcwvshunger Www.hcwvshunger.org

14 4 6 0

Wondering if any other #ILDSky pulmonologists use nail fold capillarography in clinic and if so which devices? #ILD #Pulm @atscommunity.bsky.social @accpchest.bsky.social

2 0 0 0

JUST IN: ( NASDAQ: #PULM ) SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM, ENTO, PIK, PFC on Behalf of Shareholders

#StockMarket #News

0 0 0 0

News; ( NASDAQ: #PULM ) Pulmatrix Announces Second Quarter 2024 Financial Results and Provides Corporate Update

#StockMarket #News

1 0 0 0
Say Sarcoidosis | Sarcoidosis Say Sarcoidosis is a campaign to raise awareness about sarcoidosis

at the behest of my brilliant colleague @mwsharp5.bsky.social, I was honored to #SaySarcoidosis for our patients in all their broad diversity

www.saysarcoidosis.org

🩺🧪 #Pulm @kaminskimed.bsky.social

2 2 0 0

#pulm #medsky 🧪🩺 @kaminskimed.bsky.social

5 2 0 0

There are AMAZING candidates on the ballot this year for ATS. Vote this week!

#pulm # PCCM

0 0 0 0

Hey #pulm peeps

What is the definitional and functional difference between PRISm and Nonspecific Ventilatory pattern?

Are they essentially the same thing?

(genuinely asking, this is not a #QoD)

#AlwaysLearning

@IUPCCM

0 0 0 0

Niche tweet

Weird that peak expiratory flow meters give a result in L/min but spirometry give peak expiratory flow results in L/sec

#NeedlessMath

#pulm

0 0 0 0

Need some #pulm folks who do #neuromuscular disease to run some things by about the new @AnthemInc clinical guideline on NIPPV. DM me.

0 0 0 0

I love #pulm clinic.

Consecutive patients:

35 pounds weight loss over the past 5 months and feeling great.

Still not smoking 10 months later after a lifetime of nicotine addiction.

#WhyIDoThis
#VisitNoteExclamationPoints

1 0 0 0

I just finished the @ABIMFoundation knowledge check-in for #Pulm re-certification. Put some thoughts into a SHORT video about the logistics of the test and reflections on the format. #Meded #proudtobeGIM #Medtwitter https://www.youtube.com/watch?v=C4dM2PZM_p0

0 0 0 0